scholarly journals Nutritional survey in critically ill children: a single center study in China

2020 ◽  
Vol 9 (3) ◽  
pp. 221-230
Author(s):  
Jingjing Li ◽  
Biru Li ◽  
Juan Qian ◽  
Jian Zhang ◽  
Hong Ren ◽  
...  
Keyword(s):  
Critically Ill ◽  
Critically Ill Children ◽  
Single Center ◽  
Single Center Study ◽  
Nutritional Survey ◽  
Center Study

scholarly journals COVID-19: Up to 82% critically ill patients had low Vitamin C values

2021 ◽  
Vol 20 (1) ◽  
Author(s):  
Teresa Maria Tomasa-Irriguible ◽  
Lara Bielsa-Berrocal
Keyword(s):  
Vitamin C ◽  
Critically Ill ◽  
Potential Role ◽  
Plasma Vitamin ◽  
Single Center ◽  
Berlin Definition ◽  
Single Center Study ◽  
Prevention And Treatment ◽  
Center Study

AbstractThere are limited proven therapeutic options for the prevention and treatment of COVID-19. We underwent an observational study with the aim of measure plasma vitamin C levels in a population of critically ill COVID-19 adult patients who met ARDS criteria according to the Berlin definition. This epidemiological study brings to light that up to 82% had low Vitamin C values. Notwithstanding the limitation that this is a single-center study, it nevertheless shows an important issue. Given the potential role of vitamin C in sepsis and ARDS, there is gathering interest of whether supplementation could be beneficial in COVID-19.

scholarly journals Transthyretin at Admission and Over Time as a Marker for Clinical Outcomes in Critically Ill Trauma Patients: A Prospective Single-Center Study

2019 ◽  
Vol 44 (1) ◽  
pp. 115-123
Author(s):  
Tobias Haltmeier ◽  
Kenji Inaba ◽  
Joseph Durso ◽  
Moazzam Khan ◽  
Stefano Siboni ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Critically Ill ◽  
Trauma Patients ◽  
Single Center ◽  
Single Center Study ◽  
Over Time ◽  
Center Study

Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center study

2012 ◽  
Vol 39 (5) ◽  
pp. 889-898 ◽  
Author(s):  
S. G. Oeyen ◽  
D. D. Benoit ◽  
L. Annemans ◽  
P. O. Depuydt ◽  
S. J. Van Belle ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Critically Ill ◽  
Critically Ill Patients ◽  
Single Center ◽  
Long Term Outcomes ◽  
Solid Malignancies ◽  
Single Center Study ◽  
Center Study

scholarly journals The effect of high fat dietary modification and nutritional status on the outcome of critically ill ventilated children: single-center study

2019 ◽  
Vol 62 (9) ◽  
pp. 344-352
Author(s):  
Nehal Mohamed El Koofy ◽  
Hanaa Ibrahim Rady ◽  
Shrouk Moataz Abdallah ◽  
Hafez Mahmoud Bazaraa ◽  
Walaa Ahmed Rabie ◽  
...  
Keyword(s):  
Nutritional Status ◽  
Critically Ill ◽  
Dietary Modification ◽  
Single Center ◽  
High Fat ◽  
Single Center Study ◽  
Center Study

Evaluation of an Enteral Clonidine Taper following Prolonged Dexmedetomidine Exposure in Critically Ill Children

2021 ◽  
Author(s):  
Mara F. Crabtree ◽  
Cheryl L. Sargel ◽  
Colleen P. Cloyd ◽  
Joseph D. Tobias ◽  
Mahmoud Abdel-Rasoul ◽  
...  
Keyword(s):  
Continuous Infusion ◽  
Critically Ill ◽  
Pediatric Intensive Care ◽  
Withdrawal Symptoms ◽  
Critically Ill Children ◽  
Or Management ◽  
Single Center Study ◽  
Dexmedetomidine Infusion ◽  
Center Study ◽  
Sedative Agents

AbstractThe aim of the current study is to evaluate the use of an enteral clonidine transition for the prevention or management of dexmedetomidine withdrawal symptoms in critically ill children not exposed to other continuous infusion sedative agents. A retrospective, single-center study was conducted in patients ≤ 18 years of age admitted to the pediatric intensive care unit who received a continuous infusion of dexmedetomidine for ≥ 24 hours and who were prescribed enteral clonidine within 72 hours of dexmedetomidine discontinuation. Predefined withdrawal terminology was established to assess for hypertension, tachycardia, agitation, tremors, and decreased sleep. A total of 105 patients were included and received enteral clonidine for prevention or management of dexmedetomidine withdrawal symptoms, with 13 patients (12.4%) requiring a taper modification to manage withdrawal symptoms. The median duration of dexmedetomidine infusion was 120.5 hours (95.5, 143.5) and median peak infusion rate was 1 µg/kg/h (1, 1.2). A higher cumulative dexmedetomidine dose of 119.2 µg/kg (96.6, 154.9) and duration of 142.9 hours (122.6, 158.3) were noted in patients who required a taper modification. Risk factors for dexmedetomidine withdrawal such as dexmedetomidine duration and cumulative dose may help predict patients at the highest risk of withdrawal that would benefit from an enteral clonidine taper to prevent dexmedetomidine withdrawal symptoms. An enteral clonidine taper can be effective in the prevention and management of dexmedetomidine withdrawal symptoms.

Sign in / Sign up

Export Citation Format

Share Document